China Veterinary PoC Diagnostics Market (2026-2031)
The China Veterinary PoC Diagnostics Market was valued at $87.1 Million in 2026 and projected to reach to $144.1 Million by 2031, representing a compound annual growth rate of 10.6%. China's veterinary point-of-care diagnostics market is positioned for sustained growth as the country modernizes its animal health infrastructure and regulatory frameworks.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China Veterinary PoC Diagnostics Market Trends and Insights
- This 10.6% compound annual growth rate significantly outpaces global trends, reflecting China's accelerating investment in animal health infrastructure and diagnostic capabilities.
- China's growing pet ownership, rising livestock disease surveillance requirements, and increasing adoption of rapid diagnostic technologies are driving market penetration across urban and rural veterinary practices. The Chinese market benefits from government initiatives promoting animal disease prevention and food safety standards that mandate rapid diagnostic testing.
- China's expanding middle class and pet humanization trends are elevating demand for advanced veterinary care, including point-of-care testing solutions.
- Between 2026 and 2031, China is expected to capture increasing market share within Asia Pacific, supported by domestic manufacturing capabilities and competitive pricing that position Chinese providers as regional leaders in accessible veterinary diagnostics..
Key Market Statistics
- CAGR (2026-2031) 10.6% CAGR
- Market Size, 2026 ~USD 87.1 Million
- Forecast, 2031 ~USD 144.1 Million
- Country China
China Veterinary PoC Diagnostics Market Overview
Rapid Market Expansion :
China's veterinary PoC diagnostics market is growing at 10.6% CAGR, significantly outpacing the global rate of 7.7%, driven by increased pet ownership and livestock disease management demands.
Rising Pet Ownership :
China's expanding middle class and urbanization are fueling unprecedented growth in pet ownership, creating substantial demand for accessible, rapid diagnostic solutions in companion animal healthcare.
Livestock Disease Control :
Government initiatives to strengthen animal health infrastructure and biosecurity measures are accelerating adoption of point-of-care diagnostics across China's large-scale livestock and poultry operations.
Market Valuation Growth :
The market is valued at $87.1 million in 2026 and projected to reach $144.1 million by 2031, representing a 65.5% increase over the five-year forecast period.
China Veterinary PoC Diagnostics Market Dynamics
- The convergence of rising pet ownership in urban centers, expanding livestock operations, and government investment in disease surveillance creates a favorable environment for PoC diagnostic adoption.
- Technological advancement and localized manufacturing are reducing costs and improving accessibility across both companion and production animal segments. Looking ahead to 2031, China's market will be shaped by increasing integration of digital health platforms, growing awareness of zoonotic disease risks, and strengthened veterinary standards.
- The shift toward preventive care and rapid diagnostics in both companion and livestock sectors will drive continued market expansion, with domestic manufacturers gaining competitive advantage through localized solutions tailored to China's unique animal health challenges..
Related Ecosystem
Key Takeaways
- China's veterinary PoC diagnostics market will grow from $87.1M (2026) to $144.1M (2031) at a 10.6% CAGR, outpacing global growth rates.
- China's pet ownership surge and livestock disease surveillance mandates are primary drivers accelerating diagnostic adoption across veterinary practices.
- Government food safety initiatives and animal health regulations in China are creating sustained demand for rapid point-of-care testing solutions.
- China's domestic manufacturing ecosystem and competitive pricing advantage position the country as a regional Asia Pacific leader in veterinary diagnostics by 2031.
Veterinary PoC Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | MOLECULAR DIAGNOSTICS (Technology) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 7.7% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 1.19 (2026) |
| Revenue Forecast (Billions) | ~USD 1.72 (2031) |
| Segments Covered | Product, Animal Type, Type, Technology, Livestock Type, Molecular Diagnostics |
China Veterinary PoC Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Animal Type
- Companion Animals
- Livestock
By Type
- Cat
- Cattle
- Crispr-Based
- Dog
- Horse
- Isothermal Amplification
- Other Companion Animals
- Other Livestock
- Pcr-Based
- Pig
- Poultry
By Technology
- Immunodiagnostics
- Molecular Diagnostics
- Other Technologies
By Livestock Type
- Cattle
- Other Livestock
- Pig
- Poultry
By Molecular Diagnostics
- Crispr-Based
- Isothermal Amplification
- Pcr-Based
Target Audience
- Veterinary Diagnostic Manufacturers : Companies developing or manufacturing PoC diagnostic devices need China-specific market data to guide product development, pricing strategies, and go-to-market approaches for this high-growth market.
- Private Equity & Investors : Investment firms evaluating opportunities in China's animal health sector require detailed market sizing, growth projections, and competitive analysis to assess portfolio companies and acquisition targets.
- Veterinary Clinic Networks : Large veterinary hospital chains and clinic operators in China need market intelligence to optimize diagnostic service offerings, equipment procurement, and competitive positioning strategies.
- Pharmaceutical & Biotech Companies : Animal health pharmaceutical firms expanding into diagnostics require China market insights to identify partnership opportunities, distribution channels, and complementary product development areas.
- Government & Regulatory Bodies : Chinese veterinary authorities and animal health agencies use market data to inform policy decisions, infrastructure investment priorities, and disease surveillance program development.
Key Companies in the China Veterinary PoC Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| GENERAL ELECTRIC | United States | Public Company | Commercial Engines & Services,Defense & Propulsion Technologies,Additive and Advanced Components, |
| IDEXX LABORATORIES, INC. | United States | Public Company | Companion Animal Group (in-clinic analyzers, reference labs, software, services),Livestock, Poultry and Dairy Diagnostics,Water Quality Products, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| BIONOTE | South Korea | Public Company | Veterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits, |
| BIOMéRIEUX | France | Public Company | Microbiology ID/AST systems (VITEK 2, VITEK MS, VITEK REVEAL, API, ETEST),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Sepsis, immunoassay, and specialty markers (VIDAS, Hybiome CLIA), |
| VIRBAC | France | Public Company | Companion animal parasiticides (e.g., Prevexto),Companion animal chronic-care nutrition (e.g., Vikaly, petfood),Behavior and stress management (Zenidog/Zenifel), |
GENERAL ELECTRIC
General Electric is a publicly traded United States company founded in 1892 that operates with 57,000 employees.
IDEXX LABORATORIES, INC.
IDEXX Laboratories, Inc. is a publicly traded United States company founded in 1983 with 11,000 employees.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a publicly traded United States company founded in 1956 with 125,000 employees.
BIONOTE
BioNote is a publicly traded South Korean company founded in 2003 with 298 employees.
BIOMéRIEUX
bioMérieux is a publicly traded French company founded in 1963 with 14,894 employees.
VIRBAC
Virbac is a publicly traded French company founded in 1968 with 6,442 employees.
Reasons to Buy this Report
- Market Entry Strategy : Gain detailed insights into China's unique market dynamics, regulatory landscape, and competitive positioning to develop effective market entry and localization strategies for veterinary diagnostic products.
- Growth Opportunity Identification : Identify high-growth segments within China's companion animal and livestock sectors, with specific data on pet ownership trends, disease prevalence, and diagnostic adoption rates across regions.
- Competitive Intelligence : Understand the competitive landscape specific to China, including local manufacturers, distribution channels, pricing strategies, and barriers to entry for foreign veterinary diagnostic companies.
- Investment Decision Support : Access comprehensive financial projections and market sizing data for China through 2031 to support investment decisions, partnership evaluations, and resource allocation planning.
- Regulatory and Compliance Insights : Navigate China's evolving veterinary diagnostic regulations, certification requirements, and quality standards to ensure product compliance and accelerate time-to-market for new diagnostic solutions.
Frequently asked questions
What is the projected market size for veterinary PoC diagnostics in China by 2031?
China's veterinary PoC diagnostics market is projected to reach $144.1 million by 2031, up from $87.1 million in 2026, representing a 10.6% CAGR.
What factors are driving growth in China's veterinary diagnostics market?
China's market growth is driven by rising pet ownership, government livestock disease surveillance mandates, food safety regulations, pet humanization trends, and increasing adoption of rapid diagnostic technologies in veterinary practices.
How does China's veterinary PoC diagnostics growth compare to global trends?
China's 10.6% CAGR significantly exceeds the global average of 7.7%, reflecting stronger market fundamentals, regulatory support, and accelerating veterinary infrastructure investment in the country.
What role do government regulations play in China's veterinary diagnostics market?
Government initiatives promoting animal disease prevention, food safety standards, and livestock surveillance requirements mandate rapid diagnostic testing, creating sustained demand for point-of-care solutions across China's veterinary sector.
What competitive advantages does China hold in the veterinary PoC diagnostics market?
China benefits from domestic manufacturing capabilities, competitive pricing, established supply chains, and regional distribution networks that position Chinese providers as leaders in accessible veterinary diagnostics across Asia Pacific.
RESEARCH METHODOLOGY
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.
Secondary Research
This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; and white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary PoC diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.
Primary Research
In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary PoC diagnostics market. Primary sources from the demand side include small and large animal veterinarians, veterinary clinic and hospital owners, managers of livestock farms and dairy operations, directors of veterinary diagnostic laboratories, officials from government animal health and regulatory agencies, and procurement and purchasing teams from veterinary clinics, hospitals, and farm operations.
A breakdown of the primary respondents is provided below:
Breakdown Of Primary Interviews: Supply-Side Participants, By Company Type, Designation, And Region
Note: C-level executives include CEOs, COOs, CTOs, and VPs.
Other designations include sales, marketing, and product managers.
Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the veterinary PoC diagnostics market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Veterinary PoC Diagnostics Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Market Definition
The veterinary PoC diagnostics market comprises products and technologies used for rapid, on-site diagnosis of diseases and health conditions in animals, enabling immediate clinical decision-making without reliance on centralized laboratories. The market includes consumables (such as test kits, cartridges, strips, and reagents) and instruments (including portable analyzers and handheld diagnostic devices) and covers key technologies such as molecular diagnostics (PCR-based, isothermal amplification, and CRISPR-based methods), immunodiagnostics, and other techniques, including clinical chemistry and hematology. It serves both companion animals (dogs, cats, horses, and others) and livestock (cattle, pigs, poultry, and others), with applications spanning infectious disease detection, routine health monitoring, and preventive care across veterinary clinics, farms, and field settings.
Key Stakeholders
- Veterinary PoC diagnostic kit manufacturers
- Molecular diagnostic technology providers & PoC instrument manufacturers
- Reagent & consumable suppliers
- Veterinary clinics & hospitals
- Livestock farms, dairy farms & integrated animal production companies
- Government animal health authorities & surveillance agencies
- Veterinary diagnostic laboratories
- Veterinarians & field-based animal health service providers
- Academic & veterinary research institutions
- Contract manufacturers & OEM partners
- Distributors & regional channel partners
- Market research & consulting firms
- Investors & venture capital firms
Report Objectives
- To define, describe, segment, and forecast the veterinary PoC diagnostics market by product, technology, animal type, and region, in terms of value
- To define, describe, segment, and forecast the veterinary PoC diagnostics market by product and region, in terms of volume
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall veterinary PoC diagnostics market
- To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies2
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the veterinary PoC diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the veterinary PoC diagnostics market and comprehensively analyze their core competencies and market shares
- To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships
1. Micromarkets are defined as the further segments and subsegments of the veterinary PoC diagnostics market included in the report.
2. Core competencies of companies are captured in terms of the key developments and strategies adopted by them to sustain their market positions.
Available customizations:
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of Rest of Europe veterinary PoC diagnostics market into Austria, Finland, Switzerland, and other countries
- Further breakdown of Rest of Latin America veterinary PoC diagnostics market into Colombia, Chile, and other countries
Competitive Landscape Assessment
Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary PoC diagnostics market
- Competitive leadership mapping for established players in the US
Get the Full Veterinary PoC Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Veterinary PoC Diagnostics Market.
- Canada Veterinary PoC Diagnostics Market
- US Veterinary PoC Diagnostics Market
- Germany Veterinary PoC Diagnostics Market
- UK Veterinary PoC Diagnostics Market
- France Veterinary PoC Diagnostics Market
- Italy Veterinary PoC Diagnostics Market
- Spain Veterinary PoC Diagnostics Market
- Netherlands Veterinary PoC Diagnostics Market
- Poland Veterinary PoC Diagnostics Market
- Sweden Veterinary PoC Diagnostics Market
- Japan Veterinary PoC Diagnostics Market
- India Veterinary PoC Diagnostics Market
- Australia Veterinary PoC Diagnostics Market
- South Korea Veterinary PoC Diagnostics Market
- New Zealand Veterinary PoC Diagnostics Market
- Thailand Veterinary PoC Diagnostics Market
- Brazil Veterinary PoC Diagnostics Market
- Mexico Veterinary PoC Diagnostics Market
- Argentina Veterinary PoC Diagnostics Market
- Rest Of Europe Veterinary PoC Diagnostics Market
- Rest Of Asia Pacific Veterinary PoC Diagnostics Market
- Kingdom Of Saudi Arabia (Ksa) Veterinary PoC Diagnostics Market
- Rest Of GCC Countries Veterinary PoC Diagnostics Market
- Rest Of Latin America Veterinary PoC Diagnostics Market
- United Arab Emirates (UAE) Veterinary PoC Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report